{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:20:01Z","timestamp":1778887201974,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12325-020-01351-9","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T09:04:31Z","timestamp":1588151071000},"page":"2575-2579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1365-548X","authenticated-orcid":false,"given":"Zakir","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazir","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"1351_CR1","unstructured":"World Health Organization (WHO). Coronavirus. 2020. https:\/\/www.who.int\/health-topics\/coronavirus. Accessed 23 Mar 2020."},{"key":"1351_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Coronavirus symptoms and diagnosis. 2020. https:\/\/www.cdc.gov\/coronavirus\/about\/symptoms.html. Accessed 23 Mar 2020."},{"key":"1351_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-020-00717-x","author":"Z Khan","year":"2020","unstructured":"Khan Z, Muhammad K, Ahmed A, Rahman H. Coronavirus outbreaks: prevention and management recommendations. Drugs Ther Perspect. 2020. https:\/\/doi.org\/10.1007\/s40267-020-00717-x.","journal-title":"Drugs Ther Perspect"},{"key":"1351_CR4","unstructured":"World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report\u201450. 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200310-sitrep-50-covid-19.pdf?sfvrsn=55e904fb_2. Accessed 24 Mar 2020."},{"key":"1351_CR5","unstructured":"World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report\u201484. 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200413-sitrep-84-covid-19.pdf?sfvrsn=44f511ab_2. Accessed 14 Apr 2020."},{"key":"1351_CR6","unstructured":"World Health Organization (WHO). Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acuterespiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed 25 Mar 2020."},{"key":"1351_CR7","unstructured":"Centers for Disease Control and Prevention (CDC). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html. Accessed 25 Mar 2020."},{"key":"1351_CR8","unstructured":"Food and Drug Administration (FDA). Coronavirus disease 2019 (COVID-19). 2020. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/counterterrorism-and-emerging-threats\/coronavirus-disease-2019-covid-19. Accessed 25 Mar 2020."},{"key":"1351_CR9","unstructured":"Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020. https:\/\/www.nature.com\/articles\/d41587-020-00003-1. Accessed 25 Mar 2020."},{"key":"1351_CR10","doi-asserted-by":"crossref","unstructured":"Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149\u201350. https:\/\/www.nature.com\/articles\/d41573-020-00016-0.","DOI":"10.1038\/d41573-020-00016-0"},{"key":"1351_CR11","unstructured":"Centers for Disease Control and Prevention (CDC). Information for clinicians on therapeutic options for COVID-19 patients. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html#r8. Accessed 25 Mar 2020."},{"key":"1351_CR12","unstructured":"Food and Drug Administration (FDA). Search Orphan Drug Designations and Approvals: remdesivir. 2020. https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=739020. Accessed 25 Mar 2020."},{"key":"1351_CR13","unstructured":"Smith T, Prosser T. COVID-19 drug therapy\u2014potential options. 2020. https:\/\/www.elsevier.com\/__data\/assets\/pdf_file\/0007\/988648\/COVID-19-Drug-Therapy_Mar-2020.pdf. Accessed 25 Mar 2020."},{"key":"1351_CR14","unstructured":"Centers for Disease Control and Prevention (CDC). Information for clinicians on therapeutic options for COVID-19 patients. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html. Accessed 25 Mar 2020."},{"key":"1351_CR15","doi-asserted-by":"publisher","unstructured":"Gautret P, Lagier J, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"1351_CR16","unstructured":"China Law Translate. Novel coronavirus pneumonia diagnosis and treatment plan (provisional 7th edition). 2020. https:\/\/www.chinalawtranslate.com\/en\/coronavirus-treatment-plan-7\/. Accessed 25 Mar 2020."},{"key":"1351_CR17","unstructured":"Korea Biomedical Review. 2020. https:\/\/www.koreabiomed.com\/news\/articleView.html?idxno=7428. Accessed 25 Mar 2020."},{"key":"1351_CR18","unstructured":"Devlin H, Sample I. The Guardian. What are the prospects for a Covid-19 treatment? 2020. https:\/\/www.theguardian.com\/science\/2020\/mar\/19\/prospects-treatment-coronavirus-drugs-vaccines. Accessed 25 Mar 2020."},{"key":"1351_CR19","unstructured":"The Week News. All about Cuba\u2019s \u2018wonder drug\u2019 being pitched against coronavirus. 2020. https:\/\/www.theweek.in\/news\/health\/2020\/03\/24\/all-about-Cubas-wonder-drug-being-pitched-against-coronavirus.html. Accessed 25 Mar 2020."},{"key":"1351_CR20","unstructured":"ClinicalTrials.gov. National Library of Medicine (US). 2020 Mar 11\u2014identifier NCT04303299. Various combination of protease inhibitors, oseltamivir, favipiravir, and chloroquin for treatment of COVID-19: a randomized control trial (THDMS-COVID19). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04303299. Accessed 26 Mar 2020."},{"key":"1351_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007","author":"Q Cai","year":"2020","unstructured":"Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. 2020. https:\/\/doi.org\/10.1016\/j.eng.2020.03.007.","journal-title":"Engineering"},{"key":"1351_CR22","doi-asserted-by":"publisher","unstructured":"Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477. https:\/\/doi.org\/10.1016\/j.lfs.2020.117477.","DOI":"10.1016\/j.lfs.2020.117477"},{"key":"1351_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104787","author":"L Leon Caly","year":"2020","unstructured":"Leon Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res. 2020. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787.","journal-title":"Antivir Res"},{"key":"1351_CR24","unstructured":"Zhou M. Ozone: a powerful weapon to combat COVID-19 outbreak. China.org.cn. 2020. http:\/\/www.china.org.cn\/opinion\/2020-02\/26\/content_75747237_4.htm. Accessed 26 Mar 2020"},{"key":"1351_CR25","unstructured":"Slater H. Cancer Network News. FDA approves phase III clinical trial of tocilizumab for COVID-19 pneumonia. 2020. https:\/\/www.cancernetwork.com\/news\/fda-approves-phase-iii-clinical-trial-tocilizumab-covid-19-pneumonia. Accessed 26 Mar 2020."},{"key":"1351_CR26","unstructured":"Kupferschmidt K, Cohen J. Science News. WHO launches global megatrial of the four most promising coronavirus treatments. 2020. https:\/\/www.sciencemag.org\/news\/2020\/03\/who-launches-global-megatrial-four-most-promising-coronavirus-treatments. Accessed 26 Mar 2020."},{"key":"1351_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105938","author":"CA Devaux","year":"2020","unstructured":"Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105938.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1351_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/hrt.69.5.451","volume":"69","author":"GI Cubero","year":"1993","unstructured":"Cubero GI, Reguero JJR, Ortega JMR. Restrictive cardiomyopathy caused by chloroquine. Br Heart J. 1993;69(5):451\u20132.","journal-title":"Br Heart J"},{"issue":"1","key":"1351_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2048872612471215","volume":"2","author":"E Joyce","year":"2013","unstructured":"Joyce E, Fabre A, Mahon N. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care. 2013;2(1):77\u201383. https:\/\/doi.org\/10.1177\/2048872612471215.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1351_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. NEJM. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2001282.","journal-title":"NEJM"},{"key":"1351_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/d41587-020-00003-1","author":"C Harrison","year":"2020","unstructured":"Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020. https:\/\/doi.org\/10.1038\/d41587-020-00003-1.","journal-title":"Nat Biotechnol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01351-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T09:22:51Z","timestamp":1713172971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01351-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01351-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"27 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}